Systemic therapy outperforms intraocular implant for treating uveitis
After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a...